Instem Reports Growing Demand for Cyto Study Manager Software Solution
Leading Organizations Select Cyto Study Manager to Streamline Genetic Toxicology Study Workflows
CONSHOHOCKEN, PA (BUSINESS WIRE)– October 2, 2017 - -Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce it has seen increased demand for its unique Cyto Study Manager (CSM) genetic toxicology software solution.
Leading R&D organizations across the globe, including Roche and Charles River Laboratories, have selected Cyto Study Manager to help them streamline genetic toxicology study workflows, reduce costs, increase efficiencies and improve regulatory compliance.
Cyto Study Manager, originally developed by Perceptive Instruments and now part of the Instem solutions portfolio, integrates data acquisition, auditing, reporting and study management processes into a single intuitive system that greatly improves efficiencies while ensuring data integrity during genetic toxicology studies. CSM includes modules for the comet assay, micronucleus, chromosome aberrations and more.
To support this increased demand, Instem is hosting an Express Webcast on Thursday October 5th titled “How to Create More Efficient GeneTox Study Workflows”. Webcast attendees will learn how:
- CSM is replacing multiple genetox systems with one comprehensive, easy to use solution
- CSM combines experimental set up, data collection and automatic report generation
- CSM is helping clients reduce paperwork and deliver results sooner
Gregor Grant, Executive Vice President Preclinical Solutions, Instem, said “We are delighted to see an increasing number of clients recognizing the potential of Cyto Study Manager to deliver dramatic efficiency gains in their genetic toxicology operations. CSM is an extremely flexible solution that can be easily customized to meet our clients’ individual genetox workflows.”
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600
Gary Mitchell (US HQ)